| A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma (NCT01486277) | Janssen Research & Development, LLC | 2011-11-01 |
| A Phase II Safety and Tolerability Study With SEN0014196 (NCT01521585) | Siena Biotech S.p.A. | 2011-11-01 |
| The ATLAST Long-Term Study (NCT01476917) | ApniCure, Inc. | 2011-11-01 |
| tDCS and Robotic Therapy in Stroke (NCT01828398) | University Hospital of Ferrara | 2011-11-01 |
| Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients (NCT01350154) | Rigshospitalet, Denmark | 2011-11-01 |
| Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant (NCT01506375) | BioTech Tools S.A. | 2011-11-01 |
| Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal (NCT01404000) | PharmaLundensis AB | 2011-11-01 |
| A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (NCT01448850) | MedImmune LLC | 2011-11-01 |
| Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic (NCT01541046) | The Hospital for Sick Children | 2011-11-01 |
| An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217) (NCT01458249) | Eisai Co., Ltd. | 2011-11-01 |
| Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (NCT01457885) | University of Michigan Rogel Cancer Center | 2011-11-01 |
| The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy (NCT01617837) | Umeå University | 2011-11-01 |
| A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (NCT01476696) | Eli Lilly and Company | 2011-11-01 |
| Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting (NCT01956370) | Ministry of Health and Child Welfare, Zimbabwe | 2011-11-01 |
| Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy (NCT01447654) | Henning Bundgaard | 2011-11-01 |
| mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus (NCT01486992) | Peking University | 2011-11-01 |
| Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) (NCT01512199) | Daiichi Sankyo | 2011-11-01 |
| Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT01830556) | Karolinska University Hospital | 2011-11-01 |
| Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects (NCT01165450) | University of California, San Francisco | 2011-11-01 |
| A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis (NCT02172963) | Karolinska Institutet | 2011-11-01 |
| Exercise in Women With Fibromyalgia (NCT01490281) | Universidad de Granada | 2011-11-01 |
| Second-line Chemotherapy in Castration Resistant Prostate Cancer (NCT01558219) | Tampere University Hospital | 2011-11-01 |
| Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma (NCT01718691) | SymBio Pharmaceuticals | 2011-11-01 |
| AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder (NCT01483963) | Endo USA Inc., a Keenova Therapeutics Company | 2011-11-01 |
| Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) (NCT01458587) | DUSA Pharmaceuticals, Inc. | 2011-11-01 |
| Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer (NCT01458717) | Seoul National University Hospital | 2011-11-01 |
| FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer (NCT01503372) | Charite University, Berlin, Germany | 2011-11-01 |
| Hormone Treatment in Growth Hormone and Testosterone Deficient Patients (NCT01397500) | Max-Planck-Institute of Psychiatry | 2011-11-01 |
| S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study (NCT01854749) | Fudan University | 2011-11-01 |
| A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation (NCT01459926) | Glycyx Therapeutics | 2011-11-01 |
| A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment (NCT01468077) | Hoffmann-La Roche | 2011-11-01 |
| A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease (NCT01442363) | Braintree Laboratories | 2011-11-01 |
| Role of Topical Tranexamic Acid in Total Hip Arthroplasty (NCT01866943) | Northwell Health | 2011-11-01 |
| RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression (NCT01482299) | Asan Medical Center | 2011-11-01 |
| Intravenous Acetaminophen for Craniotomy Patients (NCT01474304) | Swedish Medical Center | 2011-11-01 |
| Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD) (NCT01472991) | Targacept Inc. | 2011-11-01 |
| A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (NCT01464034) | Criterium, Inc. | 2011-11-01 |
| A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer (NCT01399684) | Genentech, Inc. | 2011-11-01 |
| Allogeneic Mesenchymal Stem Cells in Osteoarthritis (NCT01453738) | Stempeutics Research Pvt Ltd | 2011-11-01 |
| S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma (NCT01412879) | SWOG Cancer Research Network | 2011-11-01 |
| Evaluation of Functional Insulin Therapy in Type 1 Diabetic Patients (NCT01512680) | University Hospital, Montpellier | 2011-11-01 |
| Acupuncture Treatment for Gastroparesis: a Pilot Study (NCT01643577) | Johns Hopkins University | 2011-11-01 |
| Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL). (NCT01389427) | The Lymphoma Academic Research Organisation | 2011-11-01 |
| Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy (NCT01478737) | Anders Kvanta | 2011-11-01 |
| EASH Dressing on Chronic Venous Leg Ulcers (NCT01497210) | ConvaTec Inc. | 2011-11-01 |
| Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy (NCT01604096) | Regional Health and Social Care Agency, Italy | 2011-11-01 |
| A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients (NCT01408602) | Molecular Research Center, Inc. | 2011-11-01 |
| Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma (NCT01491672) | Novartis Pharmaceuticals | 2011-11-01 |
| rTMS and Conventional Physical Therapy After Stroke (NCT01875536) | Universidade Federal de Pernambuco | 2011-11-01 |
| Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease (NCT01788501) | Seoul National University Hospital | 2011-11-01 |
| Everolimus in Refractory Testicular Germ Cell Cancer (NCT01466231) | National Cancer Institute, Slovakia | 2011-11-01 |
| Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension (NCT01479010) | Virginia Commonwealth University | 2011-11-01 |
| A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes (NCT01474083) | vTv Therapeutics | 2011-11-01 |
| Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser (NCT01461694) | NHS Greater Glasgow and Clyde | 2011-11-01 |
| Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers (NCT01240525) | University College, London | 2011-11-01 |
| Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial Folds (NCT01463657) | Elastagen Pty Ltd | 2011-11-01 |
| A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer (NCT01427933) | Eli Lilly and Company | 2011-11-01 |
| Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer (NCT01477060) | Fondazione Michelangelo | 2011-11-01 |
| Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients (NCT01402401) | Novartis Pharmaceuticals | 2011-11-01 |
| Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia (NCT01485224) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2011-11-01 |
| Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis (NCT01475253) | Allergan | 2011-11-01 |
| Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer (NCT01471353) | University of Florida | 2011-11-01 |
| Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old (NCT01468272) | Chiesi Farmaceutici S.p.A. | 2011-11-01 |
| Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer (NCT01498588) | Emory University | 2011-11-01 |
| Study of Low-Magnitude, High-Frequency Vibration Treatment on Osteoporotic Hip Fracture Healing (NCT01293721) | Chinese University of Hong Kong | 2011-11-01 |
| rTMS and Retraining in Focal Hand Dystonia (NCT01738581) | University of Minnesota | 2011-11-01 |
| Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) (NCT01475266) | Nippon Kayaku Co., Ltd. | 2011-11-01 |
| Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids (NCT01458912) | Boehringer Ingelheim | 2011-11-01 |
| Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD) (NCT01381003) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2011-11-01 |
| A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer (NCT01653561) | Fudan University | 2011-11-01 |
| Comparative Study of the Magnetic-controlled Capsule Endoscopy Versus Standard Gastroscopy (NCT01903629) | Changhai Hospital | 2011-11-01 |
| Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases (NCT02277639) | Children's Hospital of Philadelphia | 2011-11-01 |
| Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy (NCT01489904) | Hospital Vall d'Hebron | 2011-11-01 |
| Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label) (NCT01433354) | Novartis Pharmaceuticals | 2011-11-01 |
| Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort (NCT01565512) | Columbia University | 2011-11-01 |
| Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL) (NCT01403246) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2011-11-01 |
| Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF) (NCT01467076) | NICHD Neonatal Research Network | 2011-11-01 |
| Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C (NCT01740089) | Biocad | 2011-11-01 |
| Brivanib Metastatic Renal Cell Carcinoma (NCT01253668) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis (NCT02278861) | Universidade Federal de Goias | 2011-11-01 |
| Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia (NCT01600053) | Thomas Kipps | 2011-11-01 |
| Provoked Craving Relief Study by NRT (NCT01476202) | GlaxoSmithKline | 2011-11-01 |
| IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD (NCT01438372) | Wayne State University | 2011-11-01 |
| Carotenoid Supplementation and Normal Ocular Health (NCT02147171) | University of Manchester | 2011-11-01 |
| A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C (NCT01482403) | Hoffmann-La Roche | 2011-11-01 |
| A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments (NCT01529112) | Eisai Inc. | 2011-11-01 |
| Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (NCT01457924) | GlaxoSmithKline | 2011-11-01 |
| Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients (NCT01291537) | Poitiers University Hospital | 2011-11-01 |
| Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma (NCT01849848) | SymBio Pharmaceuticals | 2011-11-01 |
| Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure (NCT01534663) | Columbia University | 2011-11-01 |
| The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts (NCT01475331) | Milton S. Hershey Medical Center | 2011-11-01 |
| Comparison of the BASKA Airway, a Novel Supraglottic Device, to the LMA Airway in Low Risk Female Patients (NCT01482650) | University College Hospital Galway | 2011-11-01 |
| Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) (NCT01724879) | Goethe University | 2011-11-01 |
| Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis (NCT01452308) | Gilead Sciences | 2011-11-01 |
| Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma (NCT01549886) | Spectrum Pharmaceuticals, Inc | 2011-11-01 |
| Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients (NCT01481272) | Polish Lymphoma Research Group | 2011-11-01 |
| Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection (NCT01601093) | Xiangbei Welman Pharmaceutical Co., Ltd | 2011-11-01 |
| Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") (NCT01726582) | Medical College of Wisconsin | 2011-11-01 |
| Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) (NCT01553786) | The Lymphoma Academic Research Organisation | 2011-11-01 |
| Study of a Probiotic Strain to Prevent Mastitis and to Eradicate GBS Colonization (NCT01505361) | Universidad Complutense de Madrid | 2011-11-01 |